Structured Summary
Abstract
Hexameric extracellular matrix glycoprotein transiently expressed in many developing organs and often re-expressed in tumors. It is present in the central and peripheral nervous systems as well as in smooth muscle and tendons. (From Kreis & Vale, Guidebook to the Extracellular Matrix and Adhesion Proteins, 1993, p93)
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
5 entry terms
- Cytotactin
- Hexabrachion
- Tenascin-C
- Tenascin C
- J1-200-220
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
96; was TENASCIN (NM) 1986-95
MeSH Record
Previous Indexing
- Cell Adhesion Molecules, Neuronal (1990-1995)
- Extracellular Matrix Proteins (1990-1995)
- Glycoproteins (1986-1989)
- Proteins (1986-1989)
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Tenascin. Medical Subject Headings (MeSH). 2026. Unique ID D019063. http://id.nlm.nih.gov/mesh/2026/D019063
- Tenascin. In: Wikipedia. https://en.wikipedia.org/wiki/Tenascin
- Tenascin. In: Wikidata. https://www.wikidata.org/wiki/Q1903925